Related references
Note: Only part of the references are listed.Genetic Variation in Nicotine Metabolism Predicts the Efficacy of Extended-Duration Transdermal Nicotine Therapy
C. Lerman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior
Thorgeir E. Thorgeirsson et al.
NATURE GENETICS (2010)
Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Helena Furberg et al.
NATURE GENETICS (2010)
Nicotine addiction and nicotinic receptors: lessons from genetically modified mice
Jean-Pierre Changeux
NATURE REVIEWS NEUROSCIENCE (2010)
New CYP2A6 gene deletion and conversion variants in a population of Black African descent
Jill C. Mwenifumbo et al.
PHARMACOGENOMICS (2010)
Differential contribution of genetic variation in multiple brain nicotinic cholinergic receptors to nicotine dependence: recent progress and emerging open questions
L. Greenbaum et al.
MOLECULAR PSYCHIATRY (2009)
Light and intermittent smokers: Background and perspective
Saul Shiffman
NICOTINE & TOBACCO RESEARCH (2009)
Is cancer triggered by altered signalling of nicotinic acetylcholine receptors?
Hildegard M. Schuller
NATURE REVIEWS CANCER (2009)
Progress and challenges in selected areas of tobacco carcinogenesis
Stephen S. Hecht
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer
Pengyuan Liu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
The CHRNA5-A3 Region on Chromosome 15q24-25.1 Is a Risk Factor Both for Nicotine Dependence and for Lung Cancer
Margaret R. Spitz et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
A variant associated with nicotine dependence, lung cancer and peripheral arterial disease
Thorgeir E. Thorgeirsson et al.
NATURE (2008)
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25
Rayjean J. Hung et al.
NATURE (2008)
Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1
Christopher I. Amos et al.
NATURE GENETICS (2008)
Trends in cigarette smoking: The Minnesota Heart Survey, 1980-1982 through 2000-2002
Sue Duval et al.
NICOTINE & TOBACCO RESEARCH (2008)
CYP2A6 polymorphisms and risk for tobacco-related cancers
Ana Rossini et al.
PHARMACOGENOMICS (2008)
Genetic variability in CYP2A6 and the pharmacokinetics of nicotine
Jill C. Mwenifiumbo et al.
PHARMACOGENOMICS (2007)
Expression of nicotinic acetylcholine receptor subunit genes in non-small-cell lung cancer reveals differences between smokers and nonsmokers
David Chi-Leung Lam et al.
CANCER RESEARCH (2007)
CYP2A6 genotype and the metabolism and disposition kinetics of nicotine
Neal L. Benowitz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Nicotinic receptors mediate tumorigenic action of tobacco-derived nitrosamines on immortalized oral epithelial cells
Juan Arredondo et al.
CANCER BIOLOGY & THERAPY (2006)
Genetic polymorphisms in CYP1B1, GSTA1, NQO1 and NAT2 and the risk of lung cancer
M Sorensen et al.
CANCER LETTERS (2005)
Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence
V Malaiyandi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
A myeloperoxidase polymorphism associated with reduced risk of lung cancer
MB Schabath et al.
LUNG CANCER (2002)